GALLIPROST Trademark

Trademark Overview

On Thursday, September 3, 2015, a trademark application was filed for GALLIPROST with the United States Patent and Trademark Office. The USPTO has given the GALLIPROST trademark a serial number of 79175504. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 23, 2022. This trademark is owned by Accretion Biotechnology Limited. The GALLIPROST trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic preparations for human medical use; radioisotope markers for therapeutic or diagnostic use for human use; radioactive materials for human medical purposes, namely, radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use, radioactive substances for use in nuclear medicine; radioactive substances for human medical purposes, namely, radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use, radioactive substances for use in nuclear medicine; chemical preparations for human medical purposes, namely, chemical reagents for human medical purposes; isotopes for human medical use, namely, radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use, radioactive substances for use in nuclear medicine
galliprost

General Information

Serial Number79175504
Word MarkGALLIPROST
Filing DateThursday, September 3, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 23, 2022
Registration Number4971143
Registration DateTuesday, June 7, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 22, 2016

Trademark Statements

Goods and ServicesDiagnostic preparations for human medical use; radioisotope markers for therapeutic or diagnostic use for human use; radioactive materials for human medical purposes, namely, radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use, radioactive substances for use in nuclear medicine; radioactive substances for human medical purposes, namely, radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use, radioactive substances for use in nuclear medicine; chemical preparations for human medical purposes, namely, chemical reagents for human medical purposes; isotopes for human medical use, namely, radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use, radioactive substances for use in nuclear medicine

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTheragnostics Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB
Party NameAccretion Biotechnology Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSomerset BA3 4HP
GB
Party NameAccretion Biotechnology Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSomerset BA3 4HP
GB

Trademark Events

Event DateEvent Description
Tuesday, October 3, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, September 13, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, September 13, 2023INVALIDATION PROCESSED
Wednesday, August 23, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, December 23, 2022CANCELLED SECTION 71
Monday, June 7, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, July 9, 2020NEW REPRESENTATIVE AT IB RECEIVED
Thursday, November 29, 2018NEW REPRESENTATIVE AT IB RECEIVED
Thursday, August 31, 2017CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, May 19, 2017NEW REPRESENTATIVE AT IB RECEIVED
Thursday, October 13, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, September 16, 2016FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 16, 2016FINAL DISPOSITION PROCESSED
Wednesday, September 7, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 7, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, March 22, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 22, 2016PUBLISHED FOR OPPOSITION
Friday, March 18, 2016NOTIFICATION PROCESSED BY IB
Wednesday, March 2, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 2, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 2, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 17, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 16, 2016ASSIGNED TO LIE
Sunday, February 7, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 5, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 5, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 5, 2016ASSIGNED TO LIE
Thursday, January 28, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 15, 2016REFUSAL PROCESSED BY IB
Monday, December 28, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, December 22, 2015REFUSAL PROCESSED BY MPU
Monday, December 21, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, December 20, 2015NON-FINAL ACTION WRITTEN
Thursday, December 17, 2015ASSIGNED TO EXAMINER
Friday, November 13, 2015APPLICATION FILING RECEIPT MAILED
Monday, November 9, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 6, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

galliprost radioactive human medical preparations diagnostic substances namely purposes therapeutic nuclear